BIO-key Expands Product Line and Market Reach with Launch of FIDO2 Compliant Security Keys in a Variety of Form Factors
September 27 2021 - 07:58AM
BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider
of Identity and Access Management (IAM) solutions featuring
Identity-Bound Biometrics, today announced the immediate
availability of an all-new lineup of BIO-key cryptographic security
keys compliant with the FIDO2 authentication standard. FIDO2 is the
industry’s “something you have” authentication standard addressing
the global password problem, standardizing the way applications
confirm a person’s possession of a cryptographic hardware key.
BIO-key FIDO-keys, an affordably priced FIDO2 security key lineup,
offer USB-A, USB-C, NFC, and iOS Lightning compatibility along with
FIPS 140-2 certified options with on-device biometric verification,
all backed by BIO-key’s US-based support and integration team.
BIO-key FIDO-keys deliver login credentials that are unique
across every website and never leave the user’s
possession. This security model eliminates the risks of
phishing, all forms of password theft and replay attacks. Combined
as a factor option with BIO-key’s “who you are” Identity-Bound
Biometrics, these new FIDO2 security keys allow BIO-key customers
complete flexibility to choose how they leverage the power of
biometrics in strong authentication scenarios. They can choose a
device-stored biometric FIDO2 security key, or a centrally-secured
remote biometric authenticator using BIO-key’s Identity-Bound
Biometrics. Both options are consistent with the FIDO Alliance’s
FIDO2 Authenticator Lifecycle Management for IT Administrators
white paper.
BIO-key’s FIDO-keys have many secure password-less workflow
applications and are fully supported by BIO-key’s award-winning
PortalGuard IAM platform, expanding its more than 16 supported
authentication methods for Multi-factor Authentication (MFA),
Single Sign On (SSO), and Self-service Password Reset. PortalGuard
is available in IDaaS or on-premises configurations. FIDO-keys are
also accepted for Windows 10 and Azure sign in, as well as the
hundreds of applications and WebAuthn services applications that
are FIDO2 ready.
“Customers want choices, not limitations, when implementing
multi-factor authentication for their workforce and consumer
users,” said Michael DePasquale, BIO-key Chairman and CEO. “Adding
new FIDO2 security keys to our solutions set expands the already
unmatched breadth of strong authentication methods we make
available to our customers, providing them a competitively-priced
alternative to single-choice hardware vendors,” continued
DePasquale.
More information and detailed specifications for FIDO-keys are
available on BIO-key’s website.
About BIO-key International, Inc.
(www.bio-key.com)
BIO-key has over two decades of expertise in providing
authentication technology for thousands of organizations and
millions of users and is revolutionizing authentication with
biometric-centric, multi-factor identity and access management
(IAM) solutions, including its PortalGuard IAM solution, that
provides convenient and secure access to devices, information,
applications, and high-value transactions. BIO-key's patented
software and hardware solutions, with industry leading biometric
capabilities, enable large-scale on-premises and
Identity-as-a-Service (IDaaS) solutions as well as customized
enterprise and cloud solutions.
BIO-key Safe Harbor Statement All statements
contained in this press release other than statements of historical
facts are "forward-looking statements" as defined in the Private
Securities Litigation Reform Act of 1995 (the "Act"). The words
"estimate," "project," "intends," "expects," "anticipates,"
"believes," and similar expressions are intended to identify
forward-looking statements. Such forward-looking statements are
made based on management's beliefs, as well as assumptions made by,
and information currently available to, management pursuant to the
"safe harbor" provisions of the Act. These statements are not
guarantees of future performance or events and are subject to risks
and uncertainties that may cause actual results to differ
materially from those included within or implied by such
forward-looking statements. These risks and uncertainties include,
without limitation, our history of losses and limited revenue; our
ability to raise additional capital; our ability to protect our
intellectual property; changes in business conditions; changes in
our sales strategy and product development plans; changes in the
marketplace; continued services of our executive management team;
security breaches; competition in the biometric technology
industry; market acceptance of biometric products generally and our
products under development; our ability to execute and deliver on
contracts in Africa; our ability to expand into Asia, Africa and
other foreign markets; the duration and severity of the current
coronavirus COVID-19 pandemic and its effect on our business
operations, sales cycles, personnel, and the geographic markets in
which we operate; delays in the development of products and
statements of assumption underlying any of the foregoing as well as
other factors set forth under the caption see "Risk Factors'' in
our Annual Report on Form 10-K for the year ended December 31, 2020
and other filings with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date made.
Except as required by law, the Company undertakes no obligation to
disclose any revision to these forward-looking statements whether
as a result of new information, future events, or otherwise.
Additionally, there may be other factors of which the Company is
not currently aware that may affect matters discussed in
forward-looking statements and may also cause actual results to
differ materially from those discussed. In particular, the
consequences of the coronavirus outbreak to economic conditions and
the industry in general and the financial position and operating
results of our Company, in particular, have been material, are
changing rapidly, and cannot be predicted.
Engage with BIO-key:
Facebook – Corporate:
https://www.facebook.com/BIOkeyInternational/LinkedIn – Corporate:
https://www.linkedin.com/company/bio-key-internationalTwitter –
Corporate: @BIOkeyIntl Twitter – Investors: @BIO_keyIR StockTwits:
BIO_keyIR
BIO-key Media Contact: Erin Knapp Matter
Communications BIO-key@matternow.com
914-260-3158
Investor Contacts: William Jones, David Collins
Catalyst IR BKYI@catalyst-ir.com 212-924-9800
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Feb 2024 to Mar 2024
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Mar 2023 to Mar 2024